Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 18-Aug-20 7:02 PM View:  | Bridgebio Pharma, Inc. (BBIO) | 16-Aug-20 | Payment of Exercise | 552 | $28.53 | $15,748.60 | (2%) 25.17K to 24.61K | |
| 18-Aug-20 7:02 PM View: | Bridgebio Pharma, Inc. (BBIO) | 16-Aug-20 | Option Exercise | 1,595 | -- | -- | 7% 23.57K to 25.17K | |
| 15-Nov-19 7:23 PM View: | Bridgebio Pharma, Inc. (BBIO) | 13-Nov-19 | Grant | 22,839 | -- | -- | 100% 0 to 22.84K | |
| 15-Aug-19 7:06 PM View: | Activision, Inc. (ATVI) | 13-Aug-19 | Option Exercise | 134,845 | $40.61 | $5,476,060.00 | 125% 108.04K to 242.89K | |
| 15-Aug-19 7:06 PM View: | Activision, Inc. (ATVI) | 13-Aug-19 | Market Option Sale | 134,845 | $47.80 | $6,445,270.00 | (56%) 242.89K to 108.04K | (86%) |
| 03-Jun-19 7:02 PM View: | Activision, Inc. (ATVI) | 30-May-19 | Payment of Exercise | 36,405 | $43.56 | $1,585,800.00 | (25%) 144.45K to 108.04K | (104%) |
| 14-Nov-18 7:08 PM View: | Activision, Inc. (ATVI) | 12-Nov-18 | Grant | 11,598 | -- | -- | 8% 145.52K to 157.12K | |
| 08-Nov-17 6:06 PM View: | Activision, Inc. (ATVI) | 06-Nov-17 | Grant | 10,268 | -- | -- | 8% 135.25K to 145.52K | |
| 09-Nov-16 8:07 PM View: | Activision, Inc. (ATVI) | 07-Nov-16 | Grant | 15,210 | -- | -- | 13% 120.04K to 135.25K | |
| 10-Aug-16 7:44 PM View: | Activision, Inc. (ATVI) | 08-Aug-16 | Grant | 120,044 | -- | -- | 100% 0 to 120.04K | |
| 24-Jun-15 4:20 PM View: | Valeant Pharmaceuticals Int... (BHC) | 22-Jun-15 | Payment of Exercise | 2,292 | -- | -- | 2% 122.99K to 125.28K | |
| 05-May-15 4:57 PM View: | Valeant Pharmaceuticals Int... (BHC) | 01-May-15 | Payment of Exercise | 1,921 | -- | -- | (2%) 96.06K to 94.14K | |
| 05-May-15 4:57 PM View: | Valeant Pharmaceuticals Int... (BHC) | 01-May-15 | Option Exercise | 3,675 | -- | -- | 4% 92.39K to 96.06K | |
| 28-Jan-15 5:35 PM View: | Valeant Pharmaceuticals Int... (BHC) | 26-Jan-15 | Payment of Exercise | 760 | -- | -- | (< 1%) 93.14K to 92.39K | |
| 26-Jan-15 5:22 PM View: | Valeant Pharmaceuticals Int... (BHC) | 22-Jan-15 | Payment of Exercise | 2,789 | -- | -- | (3%) 95.93K to 93.14K | |
| 26-Jan-15 5:22 PM View: | Valeant Pharmaceuticals Int... (BHC) | 22-Jan-15 | Option Exercise | 7,350 | -- | -- | 8% 88.58K to 95.93K | |
| 24-Dec-14 10:31 AM View: | Valeant Pharmaceuticals Int... (BHC) | 23-Dec-14 | Payment of Exercise | 8,034 | -- | -- | (8%) 96.62K to 88.58K | |
| 24-Dec-14 10:31 AM View: | Valeant Pharmaceuticals Int... (BHC) | 23-Dec-14 | Option Exercise | 15,426 | -- | -- | 19% 81.19K to 96.62K | |
| 30-Oct-14 5:23 PM View: | Valeant Pharmaceuticals Int... (BHC) | 28-Oct-14 | Payment of Exercise | 908 | -- | -- | (1%) 82.1K to 81.19K | |
| 27-Oct-14 5:14 PM View: | Valeant Pharmaceuticals Int... (BHC) | 23-Oct-14 | Payment of Exercise | 784 | -- | -- | (< 1%) 82.88K to 82.1K | |
| 14-Oct-14 2:51 PM View: | Valeant Pharmaceuticals Int... (BHC) | 10-Oct-14 | Payment of Exercise | 1,907 | -- | -- | (2%) 84.79K to 82.88K | |
| 14-Oct-14 2:51 PM View: | Valeant Pharmaceuticals Int... (BHC) | 10-Oct-14 | Option Exercise | 3,675 | -- | -- | 5% 81.12K to 84.79K | |
| 02-Oct-14 3:52 PM View: | Valeant Pharmaceuticals Int... (BHC) | 30-Sep-14 | Payment of Exercise | 11,948 | -- | -- | (13%) 93.06K to 81.12K | |
| 02-Oct-14 3:52 PM View: | Valeant Pharmaceuticals Int... (BHC) | 30-Sep-14 | Option Exercise | 23,030 | -- | -- | 33% 70.03K to 93.06K | |
| 07-Aug-14 3:53 PM View: | Valeant Pharmaceuticals Int... (BHC) | 06-Aug-14 | Payment of Exercise | 9,397 | -- | -- | (12%) 79.43K to 70.03K | |
| 07-Aug-14 3:53 PM View: | Valeant Pharmaceuticals Int... (BHC) | 06-Aug-14 | Option Exercise | 18,111 | -- | -- | 30% 61.32K to 79.43K | |
| 23-Jul-14 4:43 PM View: | Valeant Pharmaceuticals Int... (BHC) | 23-Jul-14 | Payment of Exercise | 867 | -- | -- | (1%) 62.19K to 61.32K | |
| 12-Feb-14 4:08 PM View: | Valeant Pharmaceuticals Int... (BHC) | 11-Feb-14 | Payment of Exercise | 7,596 | -- | -- | (11%) 69.78K to 62.19K | |
| 12-Feb-14 4:08 PM View: | Valeant Pharmaceuticals Int... (BHC) | 11-Feb-14 | Option Exercise | 14,700 | -- | -- | 27% 55.08K to 69.78K | |
| 22-Jan-14 4:55 PM View: | Valeant Pharmaceuticals Int... (BHC) | 20-Jan-14 | Payment of Exercise | 22,856 | -- | -- | (17%) 133.6K to 110.74K | |
| 22-Jan-14 4:55 PM View: | Valeant Pharmaceuticals Int... (BHC) | 20-Jan-14 | Option Exercise | 45,000 | -- | -- | 51% 88.6K to 133.6K | |
| 28-Oct-13 4:47 PM View: | Valeant Pharmaceuticals Int... (BHC) | 24-Oct-13 | Payment of Exercise | 892 | -- | -- | (2%) 43.83K to 42.94K | |
| 22-Oct-13 5:05 PM View: | Valeant Pharmaceuticals Int... (BHC) | 20-Oct-13 | Grant | 4,500 | -- | -- | 11% 39.33K to 43.83K | |
| 21-Aug-13 4:46 PM View: | Valeant Pharmaceuticals Int... (BHC) | 21-Aug-13 | Payment of Exercise | 7,525 | -- | -- | (16%) 46.86K to 39.33K | |
| 21-Aug-13 4:46 PM View: | Valeant Pharmaceuticals Int... (BHC) | 21-Aug-13 | Option Exercise | 14,700 | -- | -- | 46% 32.16K to 46.86K | |
| 12-Aug-13 6:10 PM View: | Valeant Pharmaceuticals Int... (BHC) | 12-Aug-13 | Market Purchase | 4,500 | $100.71 | $453,197.00 | 16% 27.66K to 32.16K | (76%) |
| 23-Jul-13 4:54 PM View: | Valeant Pharmaceuticals Int... (BHC) | 20-Jul-13 | Payment of Exercise | 687 | -- | -- | (2%) 28.34K to 27.66K | |
| 22-Jan-13 6:16 PM View: | Valeant Pharmaceuticals Int... (BHC) | 20-Jan-13 | Payment of Exercise | 347 | -- | -- | (1%) 28.69K to 28.34K | |
| 08-Nov-12 2:29 PM View: | Valeant Pharmaceuticals Int... (BHC) | 07-Nov-12 | Market Purchase | 2,040 | $52.76 | $107,622.00 | 8% 24.61K to 26.65K | (55%) |
| 26-Oct-12 4:25 PM View: | Valeant Pharmaceuticals Int... (BHC) | 24-Oct-12 | Payment of Exercise | 650 | -- | -- | (3%) 25.26K to 24.61K | |
| 24-Jul-12 4:20 PM View: | Valeant Pharmaceuticals Int... (BHC) | 20-Jul-12 | Grant | 5,000 | -- | -- | 25% 20.26K to 25.26K | |
| 14-May-12 5:16 PM View: | Valeant Pharmaceuticals Int... (BHC) | 10-May-12 | Market Purchase | 5,000 | $53.10 | $265,506.00 | 33% 15.26K to 20.26K | (56%) |
| 24-Jan-12 5:05 PM View: | Valeant Pharmaceuticals Int... (BHC) | 20-Jan-12 | Grant | 2,400 | -- | -- | 19% 12.86K to 15.26K | |
| 22-Jan-13 6:16 PM View: | Valeant Pharmaceuticals Int... (BHC) | 20-Jan-12 | Grant | 2,040 | -- | -- | 8% 26.65K to 28.69K | |
| 18-Nov-11 3:05 PM View: | Valeant Pharmaceuticals Int... (BHC) | 17-Nov-11 | Market Purchase | 2,400 | $42.05 | $100,920.00 | 23% 10.46K to 12.86K | (45%) |
| 26-Oct-11 5:37 PM View: | Valeant Pharmaceuticals Int... (BHC) | 24-Oct-11 | Grant | 5,230 | -- | -- | 100% 5.23K to 10.46K | |
| 30-Aug-11 4:42 PM View: | Valeant Pharmaceuticals Int... (BHC) | 26-Aug-11 | Market Purchase | 2,680 | $41.00 | $109,880.00 | 105% 2.55K to 5.23K | (43%) |
| 11-Aug-11 4:18 PM View: | Valeant Pharmaceuticals Int... (BHC) | 11-Aug-11 | Market Purchase | 1,800 | $39.21 | $70,576.00 | 240% 0.75K to 2.55K | (41%) |
| 11-Aug-11 4:18 PM View: | Valeant Pharmaceuticals Int... (BHC) | 09-Aug-11 | Market Purchase | 750 | $39.10 | $29,325.50 | 100% 0 to 0.75K | (40%) |